Related Experiment Video
Updated: Jun 25, 2026
13:06
Solubilization and Bio-conjugation of Quantum Dots and Bacterial Toxicity Assays by Growth Curve and Plate Count
Published on: July 11, 2012
Quantification techniques and biodistribution of semiconductor quantum dots.
Emilie Pic1, Lina Bezdetnaya, François Guillemin
1CRAN, Nancy-University, CNRS, Centre Alexis Vautrin, France.
Anti-Cancer Agents in Medicinal Chemistry
|March 12, 2009
Summary
This review summarizes techniques for quantifying quantum dots (QDs) in vivo and ex vivo. Understanding QD distribution and pharmacokinetics is crucial for their safe clinical use.
Area of Science:
- Biomedical Nanotechnology
- Quantum Dot Applications
- Pharmacokinetics and Biodistribution
Background:
- Quantum dots (QDs) are fluorescent nanocrystals with promising biomedical applications.
- Potential toxicity hinders clinical translation, necessitating precise in vivo distribution analysis.
- Current biodistribution studies for QDs in animal models are limited.
Purpose of the Study:
- To review techniques for quantifying quantum dots (QDs) in vivo and ex vivo.
- To highlight the importance of analyzing QD distribution and pharmacokinetics.
- To discuss methods for modifying QD biodistribution based on administration routes.
Main Methods:
- Review of fluorescence-based quantification techniques for in vivo QD analysis.
- Summary of radioactivity-based methods for ex vivo QD quantification.
- Discussion of mass spectrometry for elementary-level QD detection.
Main Results:
- Various techniques exist for relative and absolute quantification of QDs.
- Biodistribution studies are essential but currently sparse.
- Injection routes can influence QD biodistribution.
Conclusions:
- Accurate quantification methods are vital for assessing QD safety and efficacy.
- Further research on QD biodistribution is needed for clinical translation.
- Optimizing QD administration routes can enhance therapeutic outcomes.
